A Clinical Trial of Lasuna Taila Pana and Matrabasti in the Management of Artavakshaya (Oligomenorrhoea)
Phase 3
- Conditions
- Health Condition 1: N915- Oligomenorrhea, unspecified
- Registration Number
- CTRI/2023/10/058305
- Lead Sponsor
- Dr. Simanta Nath
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Bleeding or spotting less than 2 days.
2. Infrequent menses at interval longer than 35 days or scanty bleeding with minimum 3 days cycle of history of Oligomenorrhoea aur Hypomenorrhea.
4. Irrespective of gravida
5. Both married and unmarried women of age 16 to 45 years.
Exclusion Criteria
1.Patient with systemic disorder like TB, Hypertension, Asthma, Congenital anomalies or allied disease which cause oligomenorrhea or hypomenorrhea.
2.Patient with severe anaemia (HB <7 mg/DL). 3.Pregnant or lactating women.
4.Women on OCPs or IUCDs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in symptoms of Artavakshya. <br/ ><br>1.Normalise the interval between two cycles. <br/ ><br>2.To normalise the amount of blood loss. <br/ ><br>3.To normalise the duration of bleeding. <br/ ><br>4.Minimise the grade of painTimepoint: 90 Days
- Secondary Outcome Measures
Name Time Method 1.USG report to be within normal limits. <br/ ><br>2.Serum Prolactin. <br/ ><br>3.AMH. <br/ ><br>4.TSH T3 T4. <br/ ><br>5.HB%Timepoint: 90 days